The EPO published patent EP3775227A1 granting Touchlight IP Limited rights to reprogramming vectors technology in the biotechnology field. The patent lists five inventors and covers IPC classifications related to nucleic acid vectors and cell reprogramming. The designation extends to all European Patent Convention member states including AL, AT, BE, DE, FR, GB, IT, NL, and others.

Patent publications do not impose compliance obligations on third parties. Entities seeking to practice this technology should review the patent claims and consider licensing arrangements with Touchlight IP Limited. The patent provides intellectual property protection but does not create regulatory reporting or compliance requirements.